Cargando…
Hematopoietic stem cell transplant for Hurler syndrome: does using bone marrow or umbilical cord blood make a difference?
Autores principales: | Orchard, Paul J., Gupta, Ashish O., Eisengart, Julie B., Polgreen, Lynda E., Pollard, Laura M., Braunlin, Elizabeth, Pasquali, Marzia, Lund, Troy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699938/ https://www.ncbi.nlm.nih.gov/pubmed/35476057 http://dx.doi.org/10.1182/bloodadvances.2022007212 |
Ejemplares similares
-
Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation
por: Polgreen, Lynda E., et al.
Publicado: (2019) -
Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes
por: Eisengart, Julie B., et al.
Publicado: (2019) -
Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes
por: Lund, Troy C., et al.
Publicado: (2019) -
Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation
por: Polgreen, Lynda E., et al.
Publicado: (2009) -
Biochemical and clinical response after umbilical cord blood transplant in a boy with early childhood‐onset beta‐mannosidosis
por: Lund, Troy C., et al.
Publicado: (2019)